IMPDH2 is over-expressed in a range of cancers including glioblastoma, where its elevated levels drive increased synthesis of rRNA and tRNA, stabilization of the GTP-binding nucleolar protein nucleostemin and nucleolar hypertrophy [101]. Here, IMPDH2 is linked to cancer.